JP2013524817A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013524817A5 JP2013524817A5 JP2013506336A JP2013506336A JP2013524817A5 JP 2013524817 A5 JP2013524817 A5 JP 2013524817A5 JP 2013506336 A JP2013506336 A JP 2013506336A JP 2013506336 A JP2013506336 A JP 2013506336A JP 2013524817 A5 JP2013524817 A5 JP 2013524817A5
- Authority
- JP
- Japan
- Prior art keywords
- free
- protein
- serum
- concentrated feed
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006143 cell culture medium Substances 0.000 claims description 48
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
- 108010016626 Dipeptides Proteins 0.000 claims description 26
- 235000001014 amino acid Nutrition 0.000 claims description 25
- 229940024606 amino acid Drugs 0.000 claims description 25
- 150000001413 amino acids Chemical class 0.000 claims description 25
- 239000004471 Glycine Substances 0.000 claims description 17
- 235000004279 alanine Nutrition 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 16
- 238000004113 cell culture Methods 0.000 claims description 15
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 14
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 14
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 14
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 14
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 14
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 14
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 14
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 14
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 14
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 14
- 235000003704 aspartic acid Nutrition 0.000 claims description 14
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 14
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 14
- 235000018417 cysteine Nutrition 0.000 claims description 14
- 235000013922 glutamic acid Nutrition 0.000 claims description 14
- 239000004220 glutamic acid Substances 0.000 claims description 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 14
- 235000013930 proline Nutrition 0.000 claims description 14
- 235000004400 serine Nutrition 0.000 claims description 14
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 14
- 235000014393 valine Nutrition 0.000 claims description 14
- 239000004474 valine Substances 0.000 claims description 14
- 241000700605 Viruses Species 0.000 claims description 13
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 13
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 12
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 12
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 12
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 6
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 235000009697 arginine Nutrition 0.000 claims description 6
- JQDFGZKKXBEANU-IMJSIDKUSA-N Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(O)=O JQDFGZKKXBEANU-IMJSIDKUSA-N 0.000 claims description 5
- ALZVPLKYDKJKQU-XVKPBYJWSA-N Ala-Tyr Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ALZVPLKYDKJKQU-XVKPBYJWSA-N 0.000 claims description 5
- 108010070783 alanyltyrosine Proteins 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004473 Threonine Substances 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- 235000009582 asparagine Nutrition 0.000 claims description 4
- 229960001230 asparagine Drugs 0.000 claims description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 150000002402 hexoses Chemical group 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- 235000014304 histidine Nutrition 0.000 claims description 4
- 229960002591 hydroxyproline Drugs 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- 235000014705 isoleucine Nutrition 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 235000018977 lysine Nutrition 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 235000006109 methionine Nutrition 0.000 claims description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 4
- 235000008729 phenylalanine Nutrition 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- KAGMMVOJJPXKRD-TUNDHVGDSA-N (2r,5s)-2,5-diamino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]-4-oxohexanoic acid Chemical class C[C@H](N)C(=O)C([C@H](N)C(O)=O)SSC[C@H](N)C(O)=O KAGMMVOJJPXKRD-TUNDHVGDSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 102000004506 Blood Proteins Human genes 0.000 claims 6
- 108010017384 Blood Proteins Proteins 0.000 claims 6
- 239000012141 concentrate Substances 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 45
- 210000004027 cell Anatomy 0.000 description 22
- 239000002609 medium Substances 0.000 description 22
- 239000007640 basal medium Substances 0.000 description 8
- 238000012258 culturing Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 4
- 239000006052 feed supplement Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 235000004554 glutamine Nutrition 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000004850 capillary HPLC Methods 0.000 description 1
- 239000012592 cell culture supplement Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000013630 prepared media Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32764410P | 2010-04-23 | 2010-04-23 | |
| US61/327,644 | 2010-04-23 | ||
| US13/092,016 US20110262965A1 (en) | 2010-04-23 | 2011-04-21 | Cell culture medium comprising small peptides |
| US13/092,016 | 2011-04-21 | ||
| PCT/US2011/033630 WO2011133902A2 (en) | 2010-04-23 | 2011-04-22 | Cell culture medium comprising small peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016131248A Division JP2017006127A (ja) | 2010-04-23 | 2016-07-01 | 小ペプチドを含む細胞培養培地 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013524817A JP2013524817A (ja) | 2013-06-20 |
| JP2013524817A5 true JP2013524817A5 (https=) | 2014-05-29 |
| JP6016783B2 JP6016783B2 (ja) | 2016-10-26 |
Family
ID=44816118
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506336A Active JP6016783B2 (ja) | 2010-04-23 | 2011-04-22 | 小ペプチドを含む細胞培養培地 |
| JP2016131248A Withdrawn JP2017006127A (ja) | 2010-04-23 | 2016-07-01 | 小ペプチドを含む細胞培養培地 |
| JP2016220107A Active JP6367293B2 (ja) | 2010-04-23 | 2016-11-11 | 小ペプチドを含む細胞培養培地 |
| JP2018089250A Pending JP2018113996A (ja) | 2010-04-23 | 2018-05-07 | 小ペプチドを含む細胞培養培地 |
| JP2020102940A Active JP7200180B2 (ja) | 2010-04-23 | 2020-06-15 | 小ペプチドを含む細胞培養培地 |
| JP2022147887A Active JP7481407B2 (ja) | 2010-04-23 | 2022-09-16 | 小ペプチドを含む細胞培養培地 |
| JP2024071297A Pending JP2024099021A (ja) | 2010-04-23 | 2024-04-25 | 小ペプチドを含む細胞培養培地 |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016131248A Withdrawn JP2017006127A (ja) | 2010-04-23 | 2016-07-01 | 小ペプチドを含む細胞培養培地 |
| JP2016220107A Active JP6367293B2 (ja) | 2010-04-23 | 2016-11-11 | 小ペプチドを含む細胞培養培地 |
| JP2018089250A Pending JP2018113996A (ja) | 2010-04-23 | 2018-05-07 | 小ペプチドを含む細胞培養培地 |
| JP2020102940A Active JP7200180B2 (ja) | 2010-04-23 | 2020-06-15 | 小ペプチドを含む細胞培養培地 |
| JP2022147887A Active JP7481407B2 (ja) | 2010-04-23 | 2022-09-16 | 小ペプチドを含む細胞培養培地 |
| JP2024071297A Pending JP2024099021A (ja) | 2010-04-23 | 2024-04-25 | 小ペプチドを含む細胞培養培地 |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US20110262965A1 (https=) |
| EP (4) | EP3168295B1 (https=) |
| JP (7) | JP6016783B2 (https=) |
| KR (6) | KR101733834B1 (https=) |
| CN (3) | CN102892878A (https=) |
| AU (6) | AU2011242496C1 (https=) |
| DE (1) | DE202011110859U1 (https=) |
| DK (3) | DK3168295T3 (https=) |
| SG (3) | SG10201503196VA (https=) |
| WO (1) | WO2011133902A2 (https=) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110262965A1 (en) * | 2010-04-23 | 2011-10-27 | Life Technologies Corporation | Cell culture medium comprising small peptides |
| US20130130317A1 (en) * | 2010-08-02 | 2013-05-23 | Kyowa Hakko Kirin Co., Ltd | Method for producing substance |
| SG187198A1 (en) * | 2010-08-05 | 2013-03-28 | Amgen Inc | Dipeptides to enhance yield and viability from cell cultures |
| US9062106B2 (en) | 2011-04-27 | 2015-06-23 | Abbvie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| CN106635949B (zh) | 2011-12-22 | 2020-05-19 | 生命技术公司 | 细胞培养基和方法 |
| CN102533634A (zh) * | 2012-02-22 | 2012-07-04 | 江阴剑桥生物技术有限公司 | Cho细胞无血清无蛋白化学培养基 |
| WO2013147264A1 (ja) * | 2012-03-30 | 2013-10-03 | 味の素株式会社 | 硫酸化化合物を含む幹細胞増殖用培地 |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| JP6473079B2 (ja) * | 2012-05-02 | 2019-02-20 | ライフ テクノロジーズ コーポレーション | 高密度増殖およびトランスフェクション培地並びに発現増強物質の固有の組み合わせを用いる、哺乳類細胞における高収率一過性発現 |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| HK1207960A1 (en) | 2013-03-12 | 2016-02-19 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US9499614B2 (en) | 2013-03-14 | 2016-11-22 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| JP6195191B2 (ja) * | 2013-08-08 | 2017-09-13 | 極東製薬工業株式会社 | 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法 |
| JP6190205B2 (ja) * | 2013-08-08 | 2017-08-30 | 極東製薬工業株式会社 | 無タンパク質・無脂質培地馴化細胞株、その製造方法及び培地 |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9534026B2 (en) | 2013-10-31 | 2017-01-03 | China National Research Institute Of Food & Fermentation Industries | Corn active peptide additive for cell culture medium |
| CN104593318B (zh) * | 2013-10-31 | 2018-05-04 | 中国食品发酵工业研究院 | 一种用于细胞培养基的玉米活性肽添加剂 |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| US10227559B2 (en) * | 2014-04-10 | 2019-03-12 | Bayer Healthcare Llc | Compounded media powder formulation and method of preparation of liquid medium for cell culture |
| NZ726315A (en) * | 2014-05-14 | 2018-04-27 | Merial Inc | Methods for freeze-drying and rehydrating biologics |
| CN106715707A (zh) * | 2014-06-18 | 2017-05-24 | 免疫医疗公司 | 包含n‑乙酰半胱氨酸的细胞培养方法和培养基 |
| MX383347B (es) * | 2014-08-11 | 2025-03-13 | Hoffmann La Roche | Método para incrementar la velocidad de producción específica de células eucariotas. |
| EP3303555B1 (en) * | 2015-05-29 | 2020-06-24 | Merck Patent GmbH | Deep eutectic solvents and/or ionic liquids in cell culture media |
| AU2016348588A1 (en) * | 2015-11-02 | 2018-04-26 | Ares Trading S.A. | Methods for modulating production profiles of recombinant proteins in perfusion mode |
| CN108925137A (zh) * | 2016-02-22 | 2018-11-30 | 新加坡科技研究局 | 细胞培养基 |
| CN107760651A (zh) * | 2016-08-23 | 2018-03-06 | 四川科伦博泰生物医药股份有限公司 | 一种细胞培养基及生产蛋白质的方法 |
| ES2724434T3 (es) * | 2017-03-09 | 2019-09-10 | Evonik Technochemie Gmbh | Medios de cultivo que comprenden dipéptidos de N-acil-X-glutamina |
| DE102017203908B3 (de) * | 2017-03-09 | 2018-05-30 | Evonik Technochemie Gmbh | Kulturmedium, umfassend Oligopeptide |
| PL3372671T3 (pl) | 2017-03-09 | 2022-02-21 | Evonik Operations Gmbh | Pożywka hodowlana zawierająca oligopeptydy |
| CN110494559B (zh) * | 2017-03-28 | 2023-10-31 | 味之素株式会社 | 不分化地维持用培养基添加剂 |
| CN106978390B (zh) * | 2017-05-22 | 2020-11-13 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | 适用于贴壁型cho细胞的无血清培养基及培养方法 |
| GB201708655D0 (en) | 2017-05-31 | 2017-07-12 | Ucb Biopharma Sprl | Cell culture methods |
| CN107278892A (zh) * | 2017-06-26 | 2017-10-24 | 浦江县美泽生物科技有限公司 | 紫玉兰的高效组织培养方法 |
| US20200332251A1 (en) * | 2017-10-13 | 2020-10-22 | Boehringer Ingelheim International Gmbh | Perfusion medium |
| WO2019099891A1 (en) * | 2017-11-16 | 2019-05-23 | Life Technologies Corporation | Streamlined methods for making liquid media |
| WO2019121053A1 (en) * | 2017-12-20 | 2019-06-27 | Basf Se | A method for stabilizing cell culture systems using an amphiphilic graft copolymer as cell culture reagent |
| JP7759724B2 (ja) * | 2018-06-29 | 2025-10-24 | 長瀬産業株式会社 | エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用 |
| JP7197339B2 (ja) * | 2018-12-05 | 2022-12-27 | アサヒグループ食品株式会社 | コク味付与物質含有酵母の製造方法及びコク味付与物質含有酵母エキスの製造方法 |
| CN109628378B (zh) * | 2019-01-25 | 2020-07-17 | 江苏丰华生物制药有限公司 | 一种利用花生蛋白酶解物培养cho细胞的方法 |
| US20230200424A1 (en) * | 2020-04-20 | 2023-06-29 | Evonik Operations Gmbh | Compositions comprising cys-peptides |
| GB202012991D0 (en) * | 2020-08-20 | 2020-10-07 | Ucb Biopharma Sprl | Cell culture processes |
| US20240279615A1 (en) * | 2021-09-15 | 2024-08-22 | Evonik Operations Gmbh | Compositions comprising dipeptides and trace elements |
| KR20240073107A (ko) | 2021-10-05 | 2024-05-24 | 에보닉 오퍼레이션스 게엠베하 | 디펩티드의 염 및 세포 배양에서의 이의 용도 |
| EP4486755A1 (en) | 2022-03-03 | 2025-01-08 | Evonik Operations GmbH | Process to enhance viral vector production in cell-culture using glycyl-glutamine |
| AU2022458001A1 (en) * | 2022-05-12 | 2025-01-02 | Evonik Operations Gmbh | Photostabilized compositions and a method for stabilizing photosensitive components |
| CN120712343A (zh) * | 2023-02-16 | 2025-09-26 | 默克专利股份公司 | 细胞培养基 |
| KR102609654B1 (ko) * | 2023-03-23 | 2023-12-05 | 코스맥스 주식회사 | 인간 피부 유래 산물을 포함하는 미생물 배양 배지 및 이를 이용하여 배양된 혼합 미생물 배양액의 피부 개선 용도 |
| GB202318647D0 (en) | 2023-12-06 | 2024-01-17 | Ucb Biopharma Sprl | Cell culture processes |
| WO2025219232A1 (en) * | 2024-04-15 | 2025-10-23 | Evonik Operations Gmbh | Application of small peptides supplemented cell culture media for improved cell performance |
| CN118956737A (zh) * | 2024-07-17 | 2024-11-15 | 广州沃亘生物科技有限公司 | 一种长期维持df-1细胞活力的培养基及其用途 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235772A (en) * | 1978-06-21 | 1980-11-25 | Ab Kabi | Novel peptides having growth promoting activity |
| DE3206784C2 (de) * | 1982-02-25 | 1985-05-09 | Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen | Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation |
| DE3206810C2 (de) | 1982-02-25 | 1983-12-29 | Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen | N ↑2↑-L-Tyrosinyl-N ↑6↑-L-tyrosinyl-L-lysin und N ↑2↑-L-Cystinyl-N ↑6↑-L-cystinyl-L-lysin, Verfahren zu deren Herstellung und deren Verwendung |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| AU6521986A (en) * | 1985-10-22 | 1987-05-19 | Plant Genetics, Inc. | Methods and media for enhanced somatic embryogenesis |
| DE3538310A1 (de) | 1985-10-28 | 1987-04-30 | Pfrimmer Pharma | Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen |
| ES2039402T3 (es) | 1986-10-24 | 1993-10-01 | Pfrimmer Kabi Gmbh & Co. Kg | Empleo de peptidos n,n'-bis-l-aminoacido-l-cistina en preparados de aminoacidos para alimentacion oral y parenteral. |
| US5206220A (en) | 1990-04-23 | 1993-04-27 | Research Corporation Technologies, Inc. | Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| AU7775591A (en) * | 1990-04-23 | 1991-11-11 | Research Corporation Technologies, Inc. | Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| US5328844A (en) * | 1990-05-09 | 1994-07-12 | University Of Colorado Foundation, Inc. | Culture media for mammalian cells |
| DE4022267C2 (de) | 1990-07-12 | 1994-09-15 | Degussa | N-Acyldipeptide und deren Verwendung |
| US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| GB2251249B (en) | 1990-12-28 | 1995-06-21 | Mogam Biotech Res Inst | High-density medium for animal cell culture |
| WO1996026266A1 (en) * | 1995-02-23 | 1996-08-29 | Quest International B.V. | Peptides for tissue and cell culture media |
| UA68327C2 (en) * | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
| AU4330597A (en) | 1996-08-30 | 1998-03-19 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
| US20030130195A1 (en) * | 2000-01-27 | 2003-07-10 | Universite Laval | Enzymatic hydrolysate of milk proteins |
| US6759510B1 (en) | 2000-06-30 | 2004-07-06 | Becton, Dickinson And Company | Peptides for use in culture media |
| EP1345957A2 (en) * | 2000-12-20 | 2003-09-24 | Novartis AG | Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| US20030096414A1 (en) | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
| MXPA04005010A (es) * | 2001-11-26 | 2005-04-08 | Advanced Cell Tech Inc | METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS. |
| ATE386824T1 (de) | 2002-03-29 | 2008-03-15 | Merck & Co Inc | Verfahren zur virusproduktion |
| MXPA05006522A (es) * | 2002-12-23 | 2006-02-17 | Bristol Myers Squibb Co | Mejora en la calidad de producto en procesos de cultivo en celulas de mamiferos para la produccion de proteina. |
| KR20040077553A (ko) * | 2003-02-28 | 2004-09-04 | 독립행정법인농업생물자원연구소 | 견 단백질로부터 세포 생육 펩티드의 추출과 이용 |
| US20050287666A1 (en) | 2004-06-29 | 2005-12-29 | Invitrogen Corporation | Cell culture medium comprising transition metals or trace elements |
| TWI384069B (zh) | 2004-08-27 | 2013-02-01 | Pfizer Ireland Pharmaceuticals | 多胜肽之製法 |
| JP2007521832A (ja) * | 2004-09-07 | 2007-08-09 | クロネックス・ディベロップメント・インコーポレイテッド | 細胞培養からのタンパク質収量の増加において使用するための細胞株 |
| CN101087878A (zh) * | 2004-12-20 | 2007-12-12 | 味之素株式会社 | 具有肽合成活性的突变型蛋白质 |
| AU2007294731B2 (en) * | 2006-09-13 | 2014-04-17 | Abbvie Inc. | Cell culture improvements |
| EP2615167A1 (en) * | 2006-09-15 | 2013-07-17 | MedImmune, LLC | Method for eliminating DNA contaminants from viral preparations |
| WO2008035631A1 (fr) * | 2006-09-20 | 2008-03-27 | Kyowa Hakko Kogyo Co., Ltd. | Procédé de production d'une substance |
| SI2078071T1 (sl) * | 2006-11-08 | 2015-05-29 | Wyeth Llc | Racionalno zasnovana gojišča za celično kulturo |
| WO2008136398A1 (ja) | 2007-04-26 | 2008-11-13 | Chugai Seiyaku Kabushiki Kaisha | 高濃度アミノ酸含有培地を用いた細胞の培養方法 |
| JP2008276843A (ja) | 2007-04-27 | 2008-11-13 | Hitachi Ltd | レーザー駆動方法及び光ディスク記録再生装置 |
| CA2687082C (en) * | 2007-05-11 | 2014-01-14 | Amgen Inc. | Improved feed media |
| EP2173860A1 (en) | 2007-08-03 | 2010-04-14 | Campina Nederland Holding B.V. | Culture medium for eukaryotic cells |
| JP4911523B2 (ja) * | 2007-10-22 | 2012-04-04 | 国立大学法人群馬大学 | 温度応答性配列を含むデプシペプチド構造と親水性高分子構造からなるブロック共重合体 |
| WO2009060620A1 (ja) * | 2007-11-08 | 2009-05-14 | Fujifilm Corporation | ポリペプチドの製造方法 |
| JP5270239B2 (ja) * | 2008-07-08 | 2013-08-21 | 不二製油株式会社 | ペプチド性脂質低下剤 |
| US8252557B2 (en) | 2008-10-28 | 2012-08-28 | Chugai Seiyaku Kabushiki Kaisha | Peptide-containing culture medium for culturing animal cell |
| US20110262965A1 (en) | 2010-04-23 | 2011-10-27 | Life Technologies Corporation | Cell culture medium comprising small peptides |
| US20130130317A1 (en) * | 2010-08-02 | 2013-05-23 | Kyowa Hakko Kirin Co., Ltd | Method for producing substance |
| SG187198A1 (en) * | 2010-08-05 | 2013-03-28 | Amgen Inc | Dipeptides to enhance yield and viability from cell cultures |
-
2011
- 2011-04-21 US US13/092,016 patent/US20110262965A1/en not_active Abandoned
- 2011-04-22 KR KR1020127030539A patent/KR101733834B1/ko active Active
- 2011-04-22 CN CN2011800241214A patent/CN102892878A/zh active Pending
- 2011-04-22 EP EP16198499.2A patent/EP3168295B1/en active Active
- 2011-04-22 EP EP16192190.3A patent/EP3165600B1/en active Active
- 2011-04-22 CN CN201611025484.0A patent/CN106520658B/zh active Active
- 2011-04-22 KR KR1020187004947A patent/KR102109463B1/ko active Active
- 2011-04-22 SG SG10201503196VA patent/SG10201503196VA/en unknown
- 2011-04-22 SG SG10201609347RA patent/SG10201609347RA/en unknown
- 2011-04-22 AU AU2011242496A patent/AU2011242496C1/en active Active
- 2011-04-22 SG SG2012077566A patent/SG184936A1/en unknown
- 2011-04-22 DK DK16198499.2T patent/DK3168295T3/da active
- 2011-04-22 KR KR1020177020307A patent/KR101832795B1/ko active Active
- 2011-04-22 KR KR1020167032402A patent/KR101831549B1/ko active Active
- 2011-04-22 JP JP2013506336A patent/JP6016783B2/ja active Active
- 2011-04-22 DK DK11772796.6T patent/DK2561065T3/en active
- 2011-04-22 DK DK16192190.3T patent/DK3165600T3/da active
- 2011-04-22 EP EP22198872.8A patent/EP4170016A1/en active Pending
- 2011-04-22 WO PCT/US2011/033630 patent/WO2011133902A2/en not_active Ceased
- 2011-04-22 KR KR1020207012861A patent/KR102264580B1/ko active Active
- 2011-04-22 CN CN201910370730.3A patent/CN110205282B/zh active Active
- 2011-04-22 DE DE202011110859.0U patent/DE202011110859U1/de not_active Expired - Lifetime
- 2011-04-22 KR KR1020177011545A patent/KR20170051527A/ko not_active Withdrawn
- 2011-04-22 EP EP11772796.6A patent/EP2561065B1/en not_active Revoked
-
2016
- 2016-02-01 AU AU2016200611A patent/AU2016200611A1/en not_active Abandoned
- 2016-07-01 JP JP2016131248A patent/JP2017006127A/ja not_active Withdrawn
- 2016-11-09 AU AU2016256736A patent/AU2016256736B2/en active Active
- 2016-11-11 US US15/349,791 patent/US10793827B2/en active Active
- 2016-11-11 JP JP2016220107A patent/JP6367293B2/ja active Active
-
2017
- 2017-07-24 US US15/658,311 patent/US20170342371A1/en not_active Abandoned
-
2018
- 2018-03-28 AU AU2018202222A patent/AU2018202222A1/en not_active Abandoned
- 2018-04-13 AU AU2018202612A patent/AU2018202612B2/en active Active
- 2018-05-07 JP JP2018089250A patent/JP2018113996A/ja active Pending
-
2020
- 2020-06-15 JP JP2020102940A patent/JP7200180B2/ja active Active
- 2020-06-16 US US16/903,242 patent/US11365389B2/en active Active
-
2021
- 2021-01-22 AU AU2021200418A patent/AU2021200418B2/en active Active
-
2022
- 2022-05-16 US US17/745,710 patent/US20220275325A1/en not_active Abandoned
- 2022-09-16 JP JP2022147887A patent/JP7481407B2/ja active Active
-
2023
- 2023-06-26 US US18/341,636 patent/US12529029B2/en active Active
-
2024
- 2024-04-25 JP JP2024071297A patent/JP2024099021A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013524817A5 (https=) | ||
| JP7481407B2 (ja) | 小ペプチドを含む細胞培養培地 | |
| JP7185635B2 (ja) | オリゴペプチドを含む培地 | |
| WO2014110440A1 (en) | Methods for improved production and recovery of recombinant proteins from eukaryotic cell cultures | |
| CN104593317A (zh) | 一种用于细胞培养基的大豆活性肽添加剂 | |
| US20240409886A1 (en) | Culture medium comprising dipeptides | |
| CA3055237C (en) | Culture media comprising n-acyl-x-glutamine dipeptides | |
| US7101664B2 (en) | Bioactive oligopeptides | |
| CN114316065B (zh) | 小分子肽及其应用、细胞培养基、核酸分子 | |
| WO2023154948A1 (en) | Ephrin type-b receptor 4 (ephb4) agents and production thereof | |
| CN118055938A (zh) | 二肽盐及其在细胞培养中的用途 | |
| KR20230004656A (ko) | Cys-펩티드를 포함하는 조성물 |